imatinib (Ajou University)

N/A

Report date: 2026/01/22 16:42:10

Base Information

Drug Nameimatinib (Ajou University)

Drug Alias NameimatinibKDDF-201306-05

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBcr-Abl tyrosine kinase inhibitorsStem cell growth factor receptor inhibitors

TargetsStem cell growth factor receptorBcr-Abl tyrosine kinase

Therapy Area/IndicationsDiabetic Retinopathy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAjou University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAjou University

Active IndicationsN/A

Inactive IndicationsDiabetic Retinopathy

ATC CodeN/A